Interested in sharing the research? You can order print copies of many research publications.

Order Reprints

Newsletter Sign-Up

Keep up to date with NPC news and events by signing up for our e-newsletter E.V.I.dently, and our CER Daily Newsfeed.

Subscribe POLICY

Health and Productivity as a Business Strategy: A Multiemployer Study

This study, sponsored by the National Pharmaceutical Council and published in the April issue of the Journal of Occupational and Environmental Medicine (JOEM), explored methodological refinements in measuring health-related lost productivity and assessed the business implications of a full-cost approach to managing health. After measuring productivity loss among 10 employers with 51,648 employee respondents and analyzing 1.13 million medical and pharmacy claims, researchers found that health-related productivity costs significantly exceed medical and pharmacy costs - on average 2.3 to 1. In addition, depression, obesity, arthritis, back and neck pain and anxiety drive the majority of costs when looking at both productivity and medical and pharmacy costs. The study also found presenteeism -- when employees with health conditions are present at their jobs but are unable to perform at full capacity -- to be a bigger drain on productivity than absenteeism.

Due to copyright issues, this study is only available through the JOEM website.

View the press release with further details, and watch the video with Dr. Ron Loeppke, executive vice president of Alere Inc., and Dr. Pamela Hymel, corporate medical director of integrated health at Cisco Systems, about the study's findings.

Newsletter Volume

E.V.I.dently June 2015

NPC MessageDriving Health System Value Through Broader Access to DataFrom Fitbits to insurance claims databases, we capture an enormous amount of...
Newsletter Volume

E.V.I.dently May 2015

MessageStepping Back to Look at ValueNPC President Dan Leonard explains that, like beauty, the value of health care is in the eye of the beholder....
Newsletter Volume

E.V.I.dently April 2015

MessageThe Health Care Paradigm Shift: Moving From Volume to ValueAs our health care payment and delivery systems shift from volume-based to...
Newsletter Volume

E.V.I.dently March 2015

NPC MessageCER and the Environment for Health Care Decision-MakingIs comparative effectiveness research (CER) having an impact on health care...
Press Release

Specialty Medications: Shifting the Focus From “How Much” We Spend to “How Well” We Spend

Washington, DC, June 9, 2014—As health care decision-makers grapple with how to ensure access to specialty medications, the University of Michigan...
Press Release

NPC Welcomes Dr. Bryan Luce as PCORI Chief Science Officer

WASHINGTON, DC (April 24, 2013) The National Pharmaceutical Council today welcomed the news that the Patient-Centered Outcomes Research Institute (...
Press Release

Study Quantifies Impact of Pharmaceuticals on Enhanced Productivity

(WASHINGTON, DC, August 1, 2012)–The costs to employers of chronic health conditions on employee productivity are well documented, but few studies...
Press Release

Pharmaceuticals Play Key Role in Achieving ACO Quality, Cost Goals

WASHINGTON, DC, July 18, 2012–As health care providers set up accountable care organizations (ACOs) and other value-based care programs,...
Commentary and Testimony Page

Chain Drug Review – Commentary: “Health Care Outlook for 2015”

This commentary was originally published in the January 5, 2015 issue of Chain Drug Review.By: Dan Leonard, President, National Pharmaceutical...
Commentary and Testimony Page

Living Up to Its Name? The Role of Patient-Centered Research

Anyone who has ever received bad news from his or her health care provider or held a loved one’s hand when a diagnosis was delivered can understand...
Commentary and Testimony Page

The Risks of Standardized Health Care

Think about the last time you visited a medical office. Even at a specialist’s office, chances are that each person waiting for his or her name to be...
Commentary and Testimony Page

High Stakes for Setting Research Standards

What is the cost of poorly designed research? In the comparative effectiveness arena, faulty studies could mean that consumers may make important...
YouTube Videos

Access to Specialty Medications & Value-Based Insurance Design

Specialty medications have been making health care headlines because of their effectiveness and higher costs. How can we ensure that patients will...
YouTube Videos

Supporting Consumer Access to Specialty Medications Through Value-Based Insurance Design

Access to specialty medications is a particularly pressing issue for many people who rely on these treatments for conditions that are often very...
YouTube Videos

Shifting the Focus From "How Much" to "How Well" We Spend Our Health Care Dollars

A. Mark Fendrick, MD, director of the Center for Value-Based Insurance design at the University of Michigan, highlights the key findings from a...
YouTube Videos

Engaging Consumers in Today's Changing Health Care Payment and Delivery Environment

The current health care delivery system is evolving from a fee-for-service system to one that is performance-based. How does this shift impact...
Blog Post

#TBT: NPC Research—A 2014 Recap

As part of our “Throwback Thursday” blog series, we’re taking a look at a topic that’s currently in the news and tagging it with previous...
Blog Post

Specialty Pharmaceutical and Patient Care: Are We at a Tipping Point?

Last month, the Academy of Managed Care Pharmacy (AMCP) Foundation hosted a symposium, “Specialty Pharmaceutical and Patient Care: Are We at a...
Blog Post

Assessing the Value of Drugs for Formulary Decisions

Some of the National Pharmaceutical Council's (NPC) research partners participated today on a panel, "Best Practices for Assessing the Value of Drugs...
Blog Post

PCORI Grants, HEOR & FDA Guidance Top CER Tweets of the Week (July 21-25)

What were some of the popular comparative effectiveness research (CER)-related topics on Twitter this week? We saw keen interest in the Patient-...
  • 1 of 38
  • >